Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Ark Genomic Revolution Multi-Sector ETF (ARKG)

$34.54 0.03 (0.09%)

19:59 EST ARKG Stock Quote Delayed 15 Minutes

Volume:

Previous Close $34.54

Market Cap 110.71M

PE Ratio -

EPS -

Volume (Avg. Vol.) 125,400

Day's Range 34.25 - 34.84

52-Week Range 21.98 - 35.54

Dividend & Yield N/A (N/A)

ARKG Stock Predictions, Articles, and Ark Genomic Revolution Multi-Sector ETF News

From the Web

Senate backs Hahn to lead FDA

From Seeking Alpha Dec 13, 2019

In a 72-18 vote, the Senate confirmed radiation oncology specialist Stephen Hahn, M.D. as the new FDA Commissioner.ETFs: BIB, THW, ARKG, BME, GRX, IXJ, BIS, CHNA, XLV, IDNA, GDNA, KMED, XBI

House passes drug pricing bill, Senate unlikely to support

From Seeking Alpha Dec 12, 2019

By a 230-192 margin, the U.S. House of Representatives has passed legislation, championed by Speaker Nancy Pelosi, aimed at corralling spiralling drug costs.The bill's key provision would allow the fe

Why Biotech ETFs Are Surging To New Highs

From Talk Markets Dec 11, 2019

We have seen very strong M&A activity in the biotech space of late and the trend is expected to continue as big pharmaceutical companies are trying to gain an edge in the increasingly competitive cancer treatment market.

Biotech Tops In November: Best ETFs & Stocks

From Talk Markets Nov 30, 2019

Here are five biotech ETFs and stocks that led the market in November.

S&P 500 At Record High: 6 ETF Winners Of Last Week

From Talk Markets Nov 4, 2019

The market rally was driven by a better-than-expected earnings season, easing policies, trade deal optimism, and a solid jobs report. Given the bullishness, here are six ETFs that gained the most last week.

7 Biotech ETFs That Should Remain Healthy

From InvestorPlace Aug 5, 2019

The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.